{"bekendtgoerelseNoegle":{"noticeId":{"value":"09a11752-c437-4319-ba7e-1fbf82fbc467"},"noticeVersion":{"value":"01"},"noticePublicationNumber":{"value":"00407805-2024"}},"htmlDA":"\n\n \n
1 Køber
1.1 Køber
Officielt navn: Servicio Andaluz de Salud
\n
Køberens retlige status: Offentligretligt organ, der styres af en regional myndighed
\n
Den ordregivende myndigheds aktiviteter: Sundhed
\n
\n
1.1 Køber
Officielt navn: Wojewodzki Szpital Specjalistyczny W Olsztynie
\n
Køberens retlige status: Offentligretligt organ
\n
Den ordregivende myndigheds aktiviteter: Sundhed
\n
\n
1.1 Køber
Officielt navn: Reseau Des Acheteurs Hospitaliers IDF
\n
Køberens retlige status: Offentligretligt organ
\n
Den ordregivende myndigheds aktiviteter: Sundhed
\n
\n
1.1 Køber
Officielt navn: Skane Lans Landsting
\n
Køberens retlige status: Offentligretligt organ
\n
Den ordregivende myndigheds aktiviteter: Sundhed
\n
\n
1.1 Køber
Officielt navn: Sykehusinnkjop HF
\n
Køberens retlige status: Offentligretligt organ
\n
Den ordregivende myndigheds aktiviteter: Sundhed
\n
\n
1.1 Køber
Officielt navn: Turkiye Cumhuriyeti Saglik Bakanligi
\n
Køberens retlige status: Offentligretligt organ
\n
Den ordregivende myndigheds aktiviteter: Sundhed
\n
\n
1.1 Køber
Officielt navn: Servizo Galego de Saúde
\n
Køberens retlige status: Offentligretligt organ
\n
Den ordregivende myndigheds aktiviteter: Sundhed
\n
\n
1.1 Køber
Officielt navn: Region Hovedstaden
\n
Køberens retlige status: Offentligretligt organ
\n
Den ordregivende myndigheds aktiviteter: Sundhed
\n
\n
1.1 Køber
Officielt navn: NHS National Services Scotland
\n
Køberens retlige status: Offentligretligt organ
\n
Den ordregivende myndigheds aktiviteter: Sundhed
\n
\n
1.1 Køber
Officielt navn: SPMS - Servicos Partilhados do Ministerio da Saude EPE
\n
Køberens retlige status: Offentligretligt organ
\n
Den ordregivende myndigheds aktiviteter: Sundhed
\n
\n
1.1 Køber
Officielt navn: ZESPOL OPIEKI ZDROWOTNEJ W SUCHEJ BESKIDZKIEJ
\n
Køberens retlige status: Offentligretligt organ
\n
Den ordregivende myndigheds aktiviteter: Sundhed
\n
\n
1.1 Køber
Officielt navn: Azienda Regionale Per L'innovazionee Gli Acquisti SPA
\n
Køberens retlige status: Offentligretligt organ
\n
Den ordregivende myndigheds aktiviteter: Sundhed
\n
\n
1.1 Køber
Officielt navn: Servicio Aragonés de la Salud
\n
Køberens retlige status: Offentligretligt organ
\n
Den ordregivende myndigheds aktiviteter: Sundhed
\n
\n
1.1 Køber
Officielt navn: Mercurhosp asbl
\n
Køberens retlige status: Offentligretligt organ
\n
Den ordregivende myndigheds aktiviteter: Sundhed
\n
\n
1.1 Køber
Officielt navn: Sihtasutus Pohja-Eesti Regionaalhaigla
\n
Køberens retlige status: Offentligretligt organ
\n
Den ordregivende myndigheds aktiviteter: Sundhed
\n
\n
1.1 Køber
Officielt navn: 5 Ygionomiki Periferia Thessalias & Stereas Elladas
\n
Køberens retlige status: Offentligretligt organ
\n
Den ordregivende myndigheds aktiviteter: Sundhed
\n
\n
1.1 Køber
Officielt navn: Region Vasterbotten
\n
Køberens retlige status: Offentligretligt organ
\n
Den ordregivende myndigheds aktiviteter: Sundhed
\n
\n
1.1 Køber
Officielt navn: Velindre National Health Service Trust
\n
Køberens retlige status: Offentligretligt organ
\n
Den ordregivende myndigheds aktiviteter: Sundhed
\n
\n
\n
2 Procedure
2.1 Procedure
Titel: SERVICIOS DE INVESTIGACIÓN Y DESARROLLO Y SERVICIOS DE ASESORÍA RELACIONADOS: CONSULTA\n AL MERCADO ABIERTO DE PROCURE4HEALTH PARA LA FUTURA CONTRATACIÓN PRECOMERCIAL DE SERVICIOS\n DE I+D EN RELACIÓN CON LA CONSERVACIÓN DE MUESTRAS BIOLÓGICAS FRESCAS.
\n
Beskrivelse: Este Aviso de Información Previa anuncia la Consulta al Mercado Abierto realizada\n por el proyecto PROCURE4HEALTH y proporciona información sobre una posible futura\n Contratación Precomercial (PCP) de servicios de I+D relacionados con la preservación\n de muestras biológicas frescas. PROCURE4HEALTH tiene como objetivo desafiar al mercado\n para desarrollar soluciones innovadoras que mejoren la preservación de muestras biológicas\n para estudios de biología molecular. Esta iniciativa aborda la necesidad de métodos\n rentables para preservar muestras biológicas, asegurando la integridad y el alto rendimiento\n de ADN, ARN, proteínas y metabolitos, sin requerir congelación y su infraestructura\n asociada. Estos avances son cruciales para mejorar la investigación traslacional,\n optimizar la gestión de enfermedades y mejorar los resultados de los pacientes en\n el contexto de la medicina de precisión. PCP es un enfoque que permite a los compradores\n públicos adquirir I+D de varios proveedores competidores en paralelo, para comparar\n enfoques de solución alternativos e identificar las soluciones con mejor relación\n calidad-precio que el mercado puede ofrecer para satisfacer sus necesidades. Se divide\n en tres fases: diseño de la solución, implementación del prototipo y validación y\n demostración de las soluciones. En PCP, hay una distribución de riesgos y beneficios\n bajo condiciones de mercado entre el comprador público y los proveedores, y una clara\n separación entre el PCP y el despliegue de volúmenes comerciales de productos finales.\n La contratación PCP está exenta del Acuerdo sobre Contratación Pública (GPA) de la\n OMC, las directivas de contratación pública de la UE y las leyes nacionales que las\n implementan. La futura PCP se compondrá de tres fases: Fase 1. Diseño de la solución:\n La Fase 1 del PCP se ocupará del diseño de las soluciones y la verificación de su\n viabilidad técnica y económica basada en requisitos funcionales. Se implementará de\n acuerdo con los documentos de licitación en cumplimiento con los principios de contratación\n y la metodología PCP. Se seleccionarán varios proveedores de tecnología para esta\n fase. Fase 2. Implementación del prototipo: La Fase 2 del PCP se refiere al desarrollo\n de los primeros prototipos de las soluciones y su prueba en las instalaciones de los\n compradores bajo condiciones controladas. Se seleccionarán varios proveedores de tecnología\n para esta fase. Fase 3. Validación y demostración de las soluciones: La Fase 3 del\n PCP se ocupará de la prueba y validación de las soluciones seleccionadas en entornos\n operativos. Tendrá lugar en varios Estados Miembros. Se seleccionará un mínimo de\n 2 operadores por desafío para esta fase. Los operadores seleccionados conservarán\n la propiedad de los Derechos de Propiedad Intelectual (DPI) que generen durante el\n PCP y podrán utilizarlos para explotar todo el potencial de mercado de las soluciones\n desarrolladas. Este Aviso de Información Previa invita a todos los proveedores de\n tecnología interesados de los Estados Miembros de la UE y Países Asociados comprometidos\n a realizar I+D en la UE y/o Países Asociados, independientemente de su tamaño o estructura\n de gobernanza, a participar en la Consulta al Mercado Abierto. La Consulta al Mercado\n Abierto tiene como objetivos: Validar los hallazgos del análisis del estado del arte\n y la viabilidad del conjunto de disposiciones técnicas y financieras. Concienciar\n a la industria sobre la próxima contratación precomercial (PCP). Recopilar ideas de\n la industria que puedan ser utilizadas para ajustar las especificaciones de la licitación.\n La consulta al mercado puede incluir uno o más eventos, y un cuestionario para solicitar\n información del mercado. Este Aviso de Información Previa no es un compromiso de contratación.\n Las autoridades contratantes involucradas no están legalmente obligadas de ninguna\n manera por el resultado de la consulta al mercado. No se dará ventaja o desventaja\n a ningún proveedor/grupo de proveedores en detrimento de otros durante la consulta\n al mercado y el procedimiento competitivo subsiguiente para la adjudicación de contratos.\n El idioma oficial de comunicación es el inglés. El documento de la Consulta al Mercado\n Abierto se publicará en el sitio web de PROCURE4HEALTH (www.procure4health.eu). El\n proyecto ha recibido financiación del Programa Marco Horizonte Europa (HORIZON) bajo\n el acuerdo de subvención n. 101057209. Sin embargo, la Unión Europea no participará\n como autoridad contratante en la contratación
\n
2.1.1 Formål
Kontraktens art: Tjenesteydelser
\n
Primær klassificering (cpv): 73000000 Forsknings- og udviklingsvirksomhed og hermed beslægtet konsulentvirksomhed
\n
Yderligere klassificering (cpv): 85100000 Tjenesteydelser inden for sundhedsvæsenet
\n
\n
2.1.4 Generelle oplysninger
Retsgrundlag:
\n
Direktiv 2014/24/EU
\n
\n
\n
\n
3 Del
3.1 Del: PAR-0001
Titel: RESEARCH AND DEVELOPMENT SERVICES AND RELATED CONSULTANCY SERVICESOPEN MARKET CONSULTATION\n OF PROCURE4HEALTH FOR THE FUTURE PRE-COMMERCIAL PROCUREMENT OF R&D SERVICES CONCERNING\n THE PRESERVATION OF FRESH BIOLOGICAL SAMPLES
\n
Beskrivelse: This Prior Information Notice announces the Open Market Consultation conducted by\n the PROCURE4HEALTH project and provides information about a potential future Pre-Commercial\n Procurement (PCP) of R&D services concerning the preservation of fresh biological\n samples. PROCURE4HEALTH aims to challenge the market to develop innovative solutions\n for advancing the preservation of biological samples for molecular biology studies.\n This initiative addresses the need for cost-efficient methods to preserve biological\n samples - ensuring the integrity and high yield of DNA, RNA, proteins, and metabolites\n - without requiring freezing and its associated infrastructure. These advancements\n are crucial for enhancing translational research, optimizing disease management, and\n improving patient outcomes in the context of precision medicine. PCP is an approach\n that allows public procurers to buy R&D from several competing suppliers in parallel,\n to compare alternative solution approaches, and to identify the best value-for-money\n solutions that the market can deliver to address their needs. It is split into three\n phases: solution design, prototype implementation, and validation and demonstration\n of the solutions. In PCP, there is a risk-benefit sharing under market conditions\n between the public procurer and the suppliers, and a clear separation between the\n PCP and the deployment of commercial volumes of end-products. The PCP procurement\n is exempted from the WTO Government Procurement Agreement (GPA), the EU public procurement\n directives and the national laws that implement them. The future PCP will be composed\n of three phases: Phase 1. Solution design: Phase 1 of the PCP will deal with the design\n of the solutions and verification of their technical and economic feasibility based\n on functional requirements. It will be implemented according to the tender documents\n in compliance with the procurement principles and the PCP methodology. Several technology\n providers will be selected for this phase. Phase 2. Prototype implementation: Phase\n 2 of the PCP concerns the development of the first prototypes of the solutions and\n testing at the procurers’ premises under controlled conditions. Several technology\n providers will be selected for this phase. Phase 3. Validation and demonstration of\n the solutions: Phase 3 of the PCP will deal with testing and validation of the selected\n solutions in operational environments. It will take place in several Member States.\n A minimum of 2 operators per challenge will be selected for this phase. The selected\n operators will retain ownership of the Intellectual Property Rights (IPRs) that they\n will generate during the PCP and will be able to use them to exploit the full market\n potential of the developed solutions. This PIN invites all interested technology providers\n from EU Member States and Associated Countries committed to perform R&D in the EU\n and/or Associated Countries, regardless of their size or governance structure, to\n take part in the Open Market Consultation. The Open Market Consultation aims to: (1)\n Validate the findings of the state-of-the-art analysis and the viability of the set\n of technical and financial provisions. (2) Raise awareness to the industry regarding\n the upcoming pre-commercial procurement (PCP). (3) Collect insights from the industry\n which can be used to fine tune the tender specifications. The market consultation\n may include one or more events, and a questionnaire to request information from the\n market. This Prior Information Notice is not a commitment to procure. The contracting\n authorities involved are not legally bound in any way by the outcome of the market\n consultation. No advantage or disadvantage will be given to any supplier /group of\n suppliers to the detriment of others during the market consultation and the sub-sequent\n competitive procedure for the award of contracts. The official communication language\n is English. The Open Market Consultation document will be published on the PROCURE4HEALTH\n website (www.procure4health.eu). The project has received funding from the Horizon\n Europe Framework Programme (HORIZON) under grant agreement n. 101057209. However,\n the European Union will not participate as a contracting authority in the procurement.
\n
3.1.1 Formål
Kontraktens art: Tjenesteydelser
\n
Primær klassificering (cpv): 85100000 Tjenesteydelser inden for sundhedsvæsenet
\n
\n
3.1.5 Generelle oplysninger
Reserveret deltagelse: Deltagelse uden forbehold.
\n
Dette udbud er også egnet for små og mellemstore virksomheder (SMV'er)
\n
\n
3.1.7 Udbudsvilkår
Udførelsen af kontrakten skal ske inden for rammerne af programmer for beskyttet beskæftigelse: Nej
\n
\n
3.1.9 Yderligere oplysninger, mægling og gennemgang
Organisation med ansvar for mægling: Servicio Andaluz de Salud
\n
Organisation med ansvar for klager: Servicio Andaluz de Salud
\n
Organisation, der leverer yderligere oplysninger om klageprocedurerne: Servicio Andaluz de Salud
\n
\n
\n
\n
8 Organisationer
8.1 ORG-0001
Officielt navn: Servicio Andaluz de Salud
\n
Registreringsnummer: 998853621
\n
Postadresse: AVENIDA DE LA CONSTITUCION 18  
\n
By: Sevilla
\n
Postnummer: 41001
\n
Landespecifik underafdeling (NUTS): Sevilla (ES618)
\n
Land: Spanien
\n
E-mail: hello@procure4health.eu
\n
Telefon: +34954712406
\n
Internetadresse: https://www.sspa.juntadeandalucia.es/servicioandaluzdesalud/
\n
Køberprofil: https://www.sspa.juntadeandalucia.es/servicioandaluzdesalud/
\n
Denne organisations roller:
Køber
\n
Organisation med ansvar for klager
\n
Organisation, der leverer yderligere oplysninger om klageprocedurerne
\n
Organisation med ansvar for mægling
\n
\n
\n
8.1 ORG-0002
Officielt navn: ZESPOL OPIEKI ZDROWOTNEJ W SUCHEJ BESKIDZKIEJ
\n
Registreringsnummer: 950331311
\n
Postadresse: Ul Szpitalna 22  
\n
By: Sucha Beskidzka
\n
Postnummer: 34200
\n
Landespecifik underafdeling (NUTS): Krakowski (PL214)
\n
Land: Polen
\n
E-mail: hello@procure4health.eu
\n
Telefon: +34671597580
\n
Internetadresse: https://www.zozsuchabeskidzka.pl/
\n
Køberprofil: https://www.zozsuchabeskidzka.pl/
\n
Denne organisations roller:
Køber
\n
\n
\n
8.1 ORG-0003
Officielt navn: Reseau Des Acheteurs Hospitaliers IDF
\n
Registreringsnummer: 955604425
\n
Postadresse: Rue de Charonne 45  
\n
By: Paris
\n
Postnummer: 75011
\n
Landespecifik underafdeling (NUTS): Paris (FR101)
\n
Land: Frankrig
\n
E-mail: hello@procure4health.eu
\n
Telefon: +33761735053
\n
Internetadresse: https://www.resah.fr/
\n
Køberprofil: https://www.resah.fr/
\n
Denne organisations roller:
Køber
\n
\n
\n
8.1 ORG-0004
Officielt navn: Skane Lans Landsting
\n
Registreringsnummer: 998165794
\n
By: Kristianstad
\n
Postnummer: 29189
\n
Landespecifik underafdeling (NUTS): Skåne län (SE224)
\n
Land: Sverige
\n
E-mail: hello@procure4health.eu
\n
Telefon: +46(0)462868750
\n
Internetadresse: https://www.skane.se/
\n
Køberprofil: https://www.skane.se/
\n
Denne organisations roller:
Køber
\n
\n
\n
8.1 ORG-0005
Officielt navn: Sykehusinnkjop HF
\n
Registreringsnummer: 895587421
\n
Postadresse: Tollbugata 7  
\n
By: VADSØ
\n
Postnummer: 98000
\n
Landespecifik underafdeling (NUTS): Nordland (NO071)
\n
Land: Norge
\n
E-mail: hello@procure4health.eu
\n
Telefon: +4797968880
\n
Internetadresse: https://www.sykehusinnkjop.no/
\n
Køberprofil: https://www.sykehusinnkjop.no/
\n
Denne organisations roller:
Køber
\n
\n
\n
8.1 ORG-0006
Officielt navn: Turkiye Cumhuriyeti Saglik Bakanligi
\n
Registreringsnummer: 991398007
\n
Postadresse: Mithatpasa Caddesi 3  
\n
By: Ankara
\n
Postnummer: 98000
\n
Landespecifik underafdeling (NUTS): Ankara (TR510)
\n
Land: Tyrkiet
\n
E-mail: hello@procure4health.eu
\n
Telefon: (0312)4718005
\n
Internetadresse: www.saglik.gov.tr
\n
Køberprofil: www.saglik.gov.tr
\n
Denne organisations roller:
Køber
\n
\n
\n
8.1 ORG-0007
Officielt navn: Servizo Galego de Saúde
\n
Registreringsnummer: 974720409
\n
Postadresse: Edificio Administrativo San Lázaro  
\n
By: Santiago de Compostela
\n
Postnummer: 15703
\n
Landespecifik underafdeling (NUTS): A Coruña (ES111)
\n
Land: Spanien
\n
E-mail: hello@procure4health.eu
\n
Telefon: +34650652760
\n
Internetadresse: www.sergas.es
\n
Køberprofil: www.sergas.es
\n
Denne organisations roller:
Køber
\n
\n
\n
8.1 ORG-0008
Officielt navn: Region Hovedstaden
\n
Registreringsnummer: 999654744
\n
Postadresse: Kongens Vaenge 2  
\n
By: Hillerod
\n
Postnummer: 3400
\n
Landespecifik underafdeling (NUTS): Københavns omegn (DK012)
\n
Land: Danmark
\n
E-mail: hello@procure4health.eu
\n
Telefon: 23749591
\n
Internetadresse: www.regionh.dk
\n
Køberprofil: www.regionh.dk
\n
Denne organisations roller:
Køber
\n
\n
\n
8.1 ORG-0009
Officielt navn: NHS National Services Scotland
\n
Registreringsnummer: 952878143
\n
Postadresse: South Gyle Crescent 1  
\n
By: Edinburgh
\n
Postnummer: EH12 9EB
\n
Landespecifik underafdeling (NUTS): Edinburgh, City of (UKM75)
\n
Land: Det Forenede Kongerige
\n
E-mail: hello@procure4health.eu
\n
Telefon: +447909875572
\n
Internetadresse: https://nhsnss.org/
\n
Køberprofil: https://nhsnss.org/
\n
Denne organisations roller:
Køber
\n
\n
\n
8.1 ORG-0010
Officielt navn: SPMS - Servicos Partilhados do Ministerio da Saude EPE
\n
Registreringsnummer: 950932323
\n
Postadresse: Avenida da República 61  
\n
By: Lisbon
\n
Postnummer: 1050 189
\n
Landespecifik underafdeling (NUTS): Área Metropolitana de Lisboa (PT170)
\n
Land: Portugal
\n
E-mail: hello@procure4health.eu
\n
Telefon: +351924072677
\n
Internetadresse: www.spms.min-saude.pt
\n
Køberprofil: www.spms.min-saude.pt
\n
Denne organisations roller:
Køber
\n
\n
\n
8.1 ORG-0011
Officielt navn: Wojewodzki Szpital Specjalistyczny W Olsztynie
\n
Registreringsnummer: 889548201
\n
Postadresse: Ul Zolnierska 18  
\n
By: Olsztyn
\n
Postnummer: 10561
\n
Landespecifik underafdeling (NUTS): Opolski (PL524)
\n
Land: Polen
\n
E-mail: hello@procure4healyh.eu
\n
Telefon: +48895386534
\n
Internetadresse: www.wss.olsztyn.pl
\n
Køberprofil: www.wss.olsztyn.pl
\n
Denne organisations roller:
Køber
\n
\n
\n
8.1 ORG-0012
Officielt navn: Azienda Regionale Per L'innovazionee Gli Acquisti SPA
\n
Registreringsnummer: 985380127
\n
Postadresse: Via Torquato Taramelli 26  
\n
By: Milano
\n
Postnummer: 20124
\n
Landespecifik underafdeling (NUTS): Milano (ITC4C)
\n
Land: Italien
\n
E-mail: hello@procure4health.eu
\n
Telefon: +351924072677
\n
Internetadresse: www.ariaspa.it
\n
Køberprofil: www.ariaspa.it
\n
Denne organisations roller:
Køber
\n
\n
\n
8.1 ORG-0013
Officielt navn: Servicio Aragonés de la Salud
\n
Registreringsnummer: 998853427
\n
Postadresse: Via Universitas 34  
\n
By: Zaragoza
\n
Postnummer: 50071
\n
Landespecifik underafdeling (NUTS): Zaragoza (ES243)
\n
Land: Spanien
\n
E-mail: hello@procure4health.eu
\n
Telefon: +34974249011
\n
Internetadresse: https://www.aragon.es/organismos/departamento-de-sanidad/servicio-aragones-de-salud
\n
Køberprofil: https://www.aragon.es/organismos/departamento-de-sanidad/servicio-aragones-de-salud
\n
Denne organisations roller:
Køber
\n
\n
\n
8.1 ORG-0014
Officielt navn: Mercurhosp asbl
\n
Registreringsnummer: 889223348
\n
Postadresse: Chau. de Marche 604  
\n
By: Erpent
\n
Postnummer: 5101
\n
Landespecifik underafdeling (NUTS): Arr. de Bruxelles-Capitale/Arr. Brussel-Hoofdstad (BE100)
\n
Land: Belgien
\n
E-mail: hello@procure4health.eu
\n
Telefon: +32475982654
\n
Internetadresse: www.mercurhosp.be
\n
Køberprofil: www.mercurhosp.be
\n
Denne organisations roller:
Køber
\n
\n
\n
8.1 ORG-0015
Officielt navn: Sihtasutus Pohja-Eesti Regionaalhaigla
\n
Registreringsnummer: 973828494
\n
Postadresse: J Sutiste Tee 19  
\n
By: Tallin
\n
Postnummer: 13419
\n
Landespecifik underafdeling (NUTS): Põhja-Eesti (EE001)
\n
Land: Estland
\n
E-mail: hello@procure4health.eu
\n
Telefon: +3726172938
\n
Internetadresse: www.regionaalhaigla.ee
\n
Køberprofil: www.regionaalhaigla.ee
\n
Denne organisations roller:
Køber
\n
\n
\n
8.1 ORG-0016
Officielt navn: 5 Ygionomiki Periferia Thessalias & Stereas Elladas
\n
Registreringsnummer: 991750020
\n
Postadresse: Panepistimiako Nosokomio Larissas (Periochi Mezourlo)  
\n
By: Larissa
\n
Postnummer: 41110
\n
Landespecifik underafdeling (NUTS): Αχαΐα (EL632)
\n
Land: Grækenland
\n
E-mail: hello@procure4health.eu
\n
Telefon: +302413500867
\n
Internetadresse: http://www.dypethessaly.gr
\n
Køberprofil: http://www.dypethessaly.gr
\n
Denne organisations roller:
Køber
\n
\n
\n
8.1 ORG-0017
Officielt navn: Region Vasterbotten
\n
Registreringsnummer: 996375659
\n
Postadresse: Koksvagen 11  
\n
By: Umea
\n
Postnummer: 90189
\n
Landespecifik underafdeling (NUTS): Västerbottens län (SE331)
\n
Land: Sverige
\n
E-mail: hello@procure4health.eu
\n
Telefon: +4670-2166768
\n
Internetadresse: www.vll.se
\n
Køberprofil: www.vll.se
\n
Denne organisations roller:
Køber
\n
\n
\n
8.1 ORG-0019
Officielt navn: Velindre National Health Service Trust
\n
Registreringsnummer: 993725619
\n
Postadresse: Parc Nantgarw-Charnwood Court 2  
\n
By: Cardiff
\n
Postnummer: CF15 7QZ
\n
Landespecifik underafdeling (NUTS): Cardiff and Vale of Glamorgan (UKL22)
\n
Land: Det Forenede Kongerige
\n
E-mail: hello@procure4health.eu
\n
Telefon: 02921836445
\n
Internetadresse: www.velindre-tr.wales.nhs.uk
\n
Køberprofil: www.velindre-tr.wales.nhs.uk
\n
Denne organisations roller:
Køber
\n
\n
\n
\n
11 Oplysninger om bekendtgørelsen
11.1 Oplysninger om bekendtgørelsen
Identifikator for bekendtgørelsen: 09a11752-c437-4319-ba7e-1fbf82fbc467 - 01
\n
Formulartype: Planlægning
\n
Bekendtgørelsestype: Forhåndsmeddelelse eller vejledende periodisk bekendtgørelse, der kun er anvendt til informationsformål
\n
Afsendelsesdato for bekendtgørelsen: 08-07-2024 09:06 +00:00
\n
Sprog, som denne bekendtgørelse er officielt tilgængelig på: spansk engelsk
\n
\n
11.2 Oplysninger om offentliggørelsen
Bekendtgørelsesnummer: 00407805-2024
\n
EUT-S-nummer: 132/2024
\n
Offentliggørelsesdato: 09-07-2024
\n
Den påtænkte dato for offentliggørelse af en udbudsbekendtgørelse inden for denne procedure: 01-11-2024
\n
\n
\n \n","htmlEN":"\n\n \n
1 Buyer
1.1 Buyer
Official name: Servicio Andaluz de Salud
\n
Legal type of the buyer: Body governed by public law, controlled by a regional authority
\n
Activity of the contracting authority: Health
\n
\n
1.1 Buyer
Official name: Wojewodzki Szpital Specjalistyczny W Olsztynie
\n
Legal type of the buyer: Body governed by public law
\n
Activity of the contracting authority: Health
\n
\n
1.1 Buyer
Official name: Reseau Des Acheteurs Hospitaliers IDF
\n
Legal type of the buyer: Body governed by public law
\n
Activity of the contracting authority: Health
\n
\n
1.1 Buyer
Official name: Skane Lans Landsting
\n
Legal type of the buyer: Body governed by public law
\n
Activity of the contracting authority: Health
\n
\n
1.1 Buyer
Official name: Sykehusinnkjop HF
\n
Legal type of the buyer: Body governed by public law
\n
Activity of the contracting authority: Health
\n
\n
1.1 Buyer
Official name: Turkiye Cumhuriyeti Saglik Bakanligi
\n
Legal type of the buyer: Body governed by public law
\n
Activity of the contracting authority: Health
\n
\n
1.1 Buyer
Official name: Servizo Galego de Saúde
\n
Legal type of the buyer: Body governed by public law
\n
Activity of the contracting authority: Health
\n
\n
1.1 Buyer
Official name: Region Hovedstaden
\n
Legal type of the buyer: Body governed by public law
\n
Activity of the contracting authority: Health
\n
\n
1.1 Buyer
Official name: NHS National Services Scotland
\n
Legal type of the buyer: Body governed by public law
\n
Activity of the contracting authority: Health
\n
\n
1.1 Buyer
Official name: SPMS - Servicos Partilhados do Ministerio da Saude EPE
\n
Legal type of the buyer: Body governed by public law
\n
Activity of the contracting authority: Health
\n
\n
1.1 Buyer
Official name: ZESPOL OPIEKI ZDROWOTNEJ W SUCHEJ BESKIDZKIEJd
\n
Legal type of the buyer: Body governed by public law
\n
Activity of the contracting authority: Health
\n
\n
1.1 Buyer
Official name: Azienda Regionale Per L'innovazionee Gli Acquisti SPA
\n
Legal type of the buyer: Body governed by public law
\n
Activity of the contracting authority: Health
\n
\n
1.1 Buyer
Official name: Servicio Aragonés de la Salud
\n
Legal type of the buyer: Body governed by public law
\n
Activity of the contracting authority: Health
\n
\n
1.1 Buyer
Official name: Mercurhosp asbl
\n
Legal type of the buyer: Body governed by public law
\n
Activity of the contracting authority: Health
\n
\n
1.1 Buyer
Official name: Sihtasutus Pohja-Eesti Regionaalhaigla
\n
Legal type of the buyer: Body governed by public law
\n
Activity of the contracting authority: Health
\n
\n
1.1 Buyer
Official name: 5 Ygionomiki Periferia Thessalias & Stereas Elladas
\n
Legal type of the buyer: Body governed by public law
\n
Activity of the contracting authority: Health
\n
\n
1.1 Buyer
Official name: Region Vasterbotten
\n
Legal type of the buyer: Body governed by public law
\n
Activity of the contracting authority: Health
\n
\n
1.1 Buyer
Official name: Velindre National Health Service Trust
\n
Legal type of the buyer: Body governed by public law
\n
Activity of the contracting authority: Health
\n
\n
\n
2 Procedure
2.1 Procedure
Title: RESEARCH AND DEVELOPMENT SERVICES AND RELATED CONSULTANCY SERVICESOPEN MARKET CONSULTATION\n OF PROCURE4HEALTH FOR THE FUTURE PRE-COMMERCIAL PROCUREMENT OF R&D SERVICES CONCERNING\n THE PRESERVATION OF FRESH BIOLOGICAL SAMPLES.
\n
Description: This Prior Information Notice announces the Open Market Consultation conducted by\n the PROCURE4HEALTH project and provides information about a potential future Pre-Commercial\n Procurement (PCP) of R&D services concerning the preservation of fresh biological\n samples. PROCURE4HEALTH aims to challenge the market to develop innovative solutions\n for advancing the preservation of biological samples for molecular biology studies.\n This initiative addresses the need for cost-efficient methods to preserve biological\n samples - ensuring the integrity and high yield of DNA, RNA, proteins, and metabolites\n - without requiring freezing and its associated infrastructure. These advancements\n are crucial for enhancing translational research, optimizing disease management, and\n improving patient outcomes in the context of precision medicine. PCP is an approach\n that allows public procurers to buy R&D from several competing suppliers in parallel,\n to compare alternative solution approaches, and to identify the best value-for-money\n solutions that the market can deliver to address their needs. It is split into three\n phases: solution design, prototype implementation, and validation and demonstration\n of the solutions. In PCP, there is a risk-benefit sharing under market conditions\n between the public procurer and the suppliers, and a clear separation between the\n PCP and the deployment of commercial volumes of end-products. The PCP procurement\n is exempted from the WTO Government Procurement Agreement (GPA), the EU public procurement\n directives and the national laws that implement them. The future PCP will be composed\n of three phases: Phase 1. Solution design: Phase 1 of the PCP will deal with the design\n of the solutions and verification of their technical and economic feasibility based\n on functional requirements. It will be implemented according to the tender documents\n in compliance with the procurement principles and the PCP methodology. Several technology\n providers will be selected for this phase. Phase 2. Prototype implementation: Phase\n 2 of the PCP concerns the development of the first prototypes of the solutions and\n testing at the procurers’ premises under controlled conditions. Several technology\n providers will be selected for this phase. Phase 3. Validation and demonstration of\n the solutions: Phase 3 of the PCP will deal with testing and validation of the selected\n solutions in operational environments. It will take place in several Member States.\n A minimum of 2 operators per challenge will be selected for this phase. The selected\n operators will retain ownership of the Intellectual Property Rights (IPRs) that they\n will generate during the PCP and will be able to use them to exploit the full market\n potential of the developed solutions. This PIN invites all interested technology providers\n from EU Member States and Associated Countries committed to perform R&D in the EU\n and/or Associated Countries, regardless of their size or governance structure, to\n take part in the Open Market Consultation. The Open Market Consultation aims to: (1)\n Validate the findings of the state-of-the-art analysis and the viability of the set\n of technical and financial provisions. (2) Raise awareness to the industry regarding\n the upcoming pre-commercial procurement (PCP). (3) Collect insights from the industry\n which can be used to fine tune the tender specifications. The market consultation\n may include one or more events, and a questionnaire to request information from the\n market. This Prior Information Notice is not a commitment to procure. The contracting\n authorities involved are not legally bound in any way by the outcome of the market\n consultation. No advantage or disadvantage will be given to any supplier /group of\n suppliers to the detriment of others during the market consultation and the sub-sequent\n competitive procedure for the award of contracts. The official communication language\n is English. The Open Market Consultation document will be published on the PROCURE4HEALTH\n website (www.procure4health.eu). The project has received funding from the Horizon\n Europe Framework Programme (HORIZON) under grant agreement n. 101057209. However,\n the European Union will not participate as a contracting authority in the procurement
\n
2.1.1 Purpose
Main nature of the contract: Services
\n
Main classification (cpv): 73000000 Research and development services and related consultancy services
\n
Additional classification (cpv): 85100000 Health services
\n
\n
2.1.4 General information
Legal basis:
\n
Directive 2014/24/EU
\n
\n
\n
\n
3 Part
3.1 Part: PAR-0001
Title: RESEARCH AND DEVELOPMENT SERVICES AND RELATED CONSULTANCY SERVICESOPEN MARKET CONSULTATION\n OF PROCURE4HEALTH FOR THE FUTURE PRE-COMMERCIAL PROCUREMENT OF R&D SERVICES CONCERNING\n THE PRESERVATION OF FRESH BIOLOGICAL SAMPLES
\n
Description: This Prior Information Notice announces the Open Market Consultation conducted by\n the PROCURE4HEALTH project and provides information about a potential future Pre-Commercial\n Procurement (PCP) of R&D services concerning the preservation of fresh biological\n samples. PROCURE4HEALTH aims to challenge the market to develop innovative solutions\n for advancing the preservation of biological samples for molecular biology studies.\n This initiative addresses the need for cost-efficient methods to preserve biological\n samples - ensuring the integrity and high yield of DNA, RNA, proteins, and metabolites\n - without requiring freezing and its associated infrastructure. These advancements\n are crucial for enhancing translational research, optimizing disease management, and\n improving patient outcomes in the context of precision medicine. PCP is an approach\n that allows public procurers to buy R&D from several competing suppliers in parallel,\n to compare alternative solution approaches, and to identify the best value-for-money\n solutions that the market can deliver to address their needs. It is split into three\n phases: solution design, prototype implementation, and validation and demonstration\n of the solutions. In PCP, there is a risk-benefit sharing under market conditions\n between the public procurer and the suppliers, and a clear separation between the\n PCP and the deployment of commercial volumes of end-products. The PCP procurement\n is exempted from the WTO Government Procurement Agreement (GPA), the EU public procurement\n directives and the national laws that implement them. The future PCP will be composed\n of three phases: Phase 1. Solution design: Phase 1 of the PCP will deal with the design\n of the solutions and verification of their technical and economic feasibility based\n on functional requirements. It will be implemented according to the tender documents\n in compliance with the procurement principles and the PCP methodology. Several technology\n providers will be selected for this phase. Phase 2. Prototype implementation: Phase\n 2 of the PCP concerns the development of the first prototypes of the solutions and\n testing at the procurers’ premises under controlled conditions. Several technology\n providers will be selected for this phase. Phase 3. Validation and demonstration of\n the solutions: Phase 3 of the PCP will deal with testing and validation of the selected\n solutions in operational environments. It will take place in several Member States.\n A minimum of 2 operators per challenge will be selected for this phase. The selected\n operators will retain ownership of the Intellectual Property Rights (IPRs) that they\n will generate during the PCP and will be able to use them to exploit the full market\n potential of the developed solutions. This PIN invites all interested technology providers\n from EU Member States and Associated Countries committed to perform R&D in the EU\n and/or Associated Countries, regardless of their size or governance structure, to\n take part in the Open Market Consultation. The Open Market Consultation aims to: (1)\n Validate the findings of the state-of-the-art analysis and the viability of the set\n of technical and financial provisions. (2) Raise awareness to the industry regarding\n the upcoming pre-commercial procurement (PCP). (3) Collect insights from the industry\n which can be used to fine tune the tender specifications. The market consultation\n may include one or more events, and a questionnaire to request information from the\n market. This Prior Information Notice is not a commitment to procure. The contracting\n authorities involved are not legally bound in any way by the outcome of the market\n consultation. No advantage or disadvantage will be given to any supplier /group of\n suppliers to the detriment of others during the market consultation and the sub-sequent\n competitive procedure for the award of contracts. The official communication language\n is English. The Open Market Consultation document will be published on the PROCURE4HEALTH\n website (www.procure4health.eu). The project has received funding from the Horizon\n Europe Framework Programme (HORIZON) under grant agreement n. 101057209. However,\n the European Union will not participate as a contracting authority in the procurement.
\n
3.1.1 Purpose
Main nature of the contract: Services
\n
Main classification (cpv): 85100000 Health services
\n
\n
3.1.5 General information
Reserved participation: Participation is not reserved.
\n
This procurement is also suitable for small and medium-sized enterprises (SMEs)
\n
\n
3.1.7 Terms of procurement
The execution of the contract must be performed within the framework of sheltered employment programmes: No
\n
\n
3.1.9 Further information, mediation and review
Mediation organisation: Servicio Andaluz de Salud
\n
Review organisation: Servicio Andaluz de Salud
\n
Organisation providing more information on the review procedures: Servicio Andaluz de Salud
\n
\n
\n
\n
8 Organisations
8.1 ORG-0001
Official name: Servicio Andaluz de Salud
\n
Registration number: 998853621
\n
Postal address: AVENIDA DE LA CONSTITUCION 18  
\n
Town: Sevilla
\n
Postcode: 41001
\n
Country subdivision (NUTS): Sevilla (ES618)
\n
Country: Spain
\n
Email: hello@procure4health.eu
\n
Telephone: +34954712406
\n
Internet address: https://www.sspa.juntadeandalucia.es/servicioandaluzdesalud/
\n
Buyer profile: https://www.sspa.juntadeandalucia.es/servicioandaluzdesalud/
\n
Roles of this organisation:
Buyer
\n
Review organisation
\n
Organisation providing more information on the review procedures
\n
Mediation organisation
\n
\n
\n
8.1 ORG-0002
Official name: ZESPOL OPIEKI ZDROWOTNEJ W SUCHEJ BESKIDZKIEJd
\n
Registration number: 950331311
\n
Postal address: Ul Szpitalna 22  
\n
Town: Sucha Beskidzka
\n
Postcode: 34200
\n
Country subdivision (NUTS): Krakowski (PL214)
\n
Country: Poland
\n
Email: hello@procure4health.eu
\n
Telephone: +34671597580
\n
Internet address: https://www.zozsuchabeskidzka.pl/
\n
Buyer profile: https://www.zozsuchabeskidzka.pl/
\n
Roles of this organisation:
Buyer
\n
\n
\n
8.1 ORG-0003
Official name: Reseau Des Acheteurs Hospitaliers IDF
\n
Registration number: 955604425
\n
Postal address: Rue de Charonne 45  
\n
Town: Paris
\n
Postcode: 75011
\n
Country subdivision (NUTS): Paris (FR101)
\n
Country: France
\n
Email: hello@procure4health.eu
\n
Telephone: +33761735053
\n
Internet address: https://www.resah.fr/
\n
Buyer profile: https://www.resah.fr/
\n
Roles of this organisation:
Buyer
\n
\n
\n
8.1 ORG-0004
Official name: Skane Lans Landsting
\n
Registration number: 998165794
\n
Town: Kristianstad
\n
Postcode: 29189
\n
Country subdivision (NUTS): Skåne län (SE224)
\n
Country: Sweden
\n
Email: hello@procure4health.eu
\n
Telephone: +46(0)462868750
\n
Internet address: https://www.skane.se/
\n
Buyer profile: https://www.skane.se/
\n
Roles of this organisation:
Buyer
\n
\n
\n
8.1 ORG-0005
Official name: Sykehusinnkjop HF
\n
Registration number: 895587421
\n
Postal address: Tollbugata 7  
\n
Town: VADSØ
\n
Postcode: 98000
\n
Country subdivision (NUTS): Nordland (NO071)
\n
Country: Norway
\n
Email: hello@procure4health.eu
\n
Telephone: +4797968880
\n
Internet address: https://www.sykehusinnkjop.no/
\n
Buyer profile: https://www.sykehusinnkjop.no/
\n
Roles of this organisation:
Buyer
\n
\n
\n
8.1 ORG-0006
Official name: Turkiye Cumhuriyeti Saglik Bakanligi
\n
Registration number: 991398007
\n
Postal address: Mithatpasa Caddesi 3  
\n
Town: Ankara
\n
Postcode: 98000
\n
Country subdivision (NUTS): Ankara (TR510)
\n
Country: Türkiye
\n
Email: hello@procure4health.eu
\n
Telephone: (0312)4718005
\n
Internet address: www.saglik.gov.tr
\n
Buyer profile: www.saglik.gov.tr
\n
Roles of this organisation:
Buyer
\n
\n
\n
8.1 ORG-0007
Official name: Servizo Galego de Saúde
\n
Registration number: 974720409
\n
Postal address: Edificio Administrativo San Lázaro  
\n
Town: Santiago de Compostela
\n
Postcode: 15703
\n
Country subdivision (NUTS): A Coruña (ES111)
\n
Country: Spain
\n
Email: hello@procure4health.eu
\n
Telephone: +34650652760
\n
Internet address: www.sergas.es
\n
Buyer profile: www.sergas.es
\n
Roles of this organisation:
Buyer
\n
\n
\n
8.1 ORG-0008
Official name: Region Hovedstaden
\n
Registration number: 999654744
\n
Postal address: Kongens Vaenge 2  
\n
Town: Hillerod
\n
Postcode: 3400
\n
Country subdivision (NUTS): Københavns omegn (DK012)
\n
Country: Denmark
\n
Email: hello@procure4health.eu
\n
Telephone: 23749591
\n
Internet address: www.regionh.dk
\n
Buyer profile: www.regionh.dk
\n
Roles of this organisation:
Buyer
\n
\n
\n
8.1 ORG-0009
Official name: NHS National Services Scotland
\n
Registration number: 952878143
\n
Postal address: South Gyle Crescent 1  
\n
Town: Edinburgh
\n
Postcode: EH12 9EB
\n
Country subdivision (NUTS): Edinburgh, City of (UKM75)
\n
Country: United Kingdom
\n
Email: hello@procure4health.eu
\n
Telephone: +447909875572
\n
Internet address: https://nhsnss.org/
\n
Buyer profile: https://nhsnss.org/
\n
Roles of this organisation:
Buyer
\n
\n
\n
8.1 ORG-0010
Official name: SPMS - Servicos Partilhados do Ministerio da Saude EPE
\n
Registration number: 950932323
\n
Postal address: Avenida da República 61  
\n
Town: Lisbon
\n
Postcode: 1050 189
\n
Country subdivision (NUTS): Área Metropolitana de Lisboa (PT170)
\n
Country: Portugal
\n
Email: hello@procure4health.eu
\n
Telephone: +351924072677
\n
Internet address: www.spms.min-saude.pt
\n
Buyer profile: www.spms.min-saude.pt
\n
Roles of this organisation:
Buyer
\n
\n
\n
8.1 ORG-0011
Official name: Wojewodzki Szpital Specjalistyczny W Olsztynie
\n
Registration number: 889548201
\n
Postal address: Ul Zolnierska 18  
\n
Town: Olsztyn
\n
Postcode: 10561
\n
Country subdivision (NUTS): Opolski (PL524)
\n
Country: Poland
\n
Email: hello@procure4healyh.eu
\n
Telephone: +48895386534
\n
Internet address: www.wss.olsztyn.pl
\n
Buyer profile: www.wss.olsztyn.pl
\n
Roles of this organisation:
Buyer
\n
\n
\n
8.1 ORG-0012
Official name: Azienda Regionale Per L'innovazionee Gli Acquisti SPA
\n
Registration number: 985380127
\n
Postal address: Via Torquato Taramelli 26  
\n
Town: Milano
\n
Postcode: 20124
\n
Country subdivision (NUTS): Milano (ITC4C)
\n
Country: Italy
\n
Email: hello@procure4health.eu
\n
Telephone: +351924072677
\n
Internet address: www.ariaspa.it
\n
Buyer profile: www.ariaspa.it
\n
Roles of this organisation:
Buyer
\n
\n
\n
8.1 ORG-0013
Official name: Servicio Aragonés de la Salud
\n
Registration number: 998853427
\n
Postal address: Via Universitas 34  
\n
Town: Zaragoza
\n
Postcode: 50071
\n
Country subdivision (NUTS): Zaragoza (ES243)
\n
Country: Spain
\n
Email: hello@procure4health.eu
\n
Telephone: +34974249011
\n
Internet address: https://www.aragon.es/organismos/departamento-de-sanidad/servicio-aragones-de-salud
\n
Buyer profile: https://www.aragon.es/organismos/departamento-de-sanidad/servicio-aragones-de-salud
\n
Roles of this organisation:
Buyer
\n
\n
\n
8.1 ORG-0014
Official name: Mercurhosp asbl
\n
Registration number: 889223348
\n
Postal address: Chau. de Marche 604  
\n
Town: Erpent
\n
Postcode: 5101
\n
Country subdivision (NUTS): Arr. de Bruxelles-Capitale/Arr. Brussel-Hoofdstad (BE100)
\n
Country: Belgium
\n
Email: hello@procure4health.eu
\n
Telephone: +32475982654
\n
Internet address: www.mercurhosp.be
\n
Buyer profile: www.mercurhosp.be
\n
Roles of this organisation:
Buyer
\n
\n
\n
8.1 ORG-0015
Official name: Sihtasutus Pohja-Eesti Regionaalhaigla
\n
Registration number: 973828494
\n
Postal address: J Sutiste Tee 19  
\n
Town: Tallin
\n
Postcode: 13419
\n
Country subdivision (NUTS): Põhja-Eesti (EE001)
\n
Country: Estonia
\n
Email: hello@procure4health.eu
\n
Telephone: +3726172938
\n
Internet address: www.regionaalhaigla.ee
\n
Buyer profile: www.regionaalhaigla.ee
\n
Roles of this organisation:
Buyer
\n
\n
\n
8.1 ORG-0016
Official name: 5 Ygionomiki Periferia Thessalias & Stereas Elladas
\n
Registration number: 991750020
\n
Postal address: Panepistimiako Nosokomio Larissas (Periochi Mezourlo)  
\n
Town: Larissa
\n
Postcode: 41110
\n
Country subdivision (NUTS): Αχαΐα (EL632)
\n
Country: Greece
\n
Email: hello@procure4health.eu
\n
Telephone: +302413500867
\n
Internet address: http://www.dypethessaly.gr
\n
Buyer profile: http://www.dypethessaly.gr
\n
Roles of this organisation:
Buyer
\n
\n
\n
8.1 ORG-0017
Official name: Region Vasterbotten
\n
Registration number: 996375659
\n
Postal address: Koksvagen 11  
\n
Town: Umea
\n
Postcode: 90189
\n
Country subdivision (NUTS): Västerbottens län (SE331)
\n
Country: Sweden
\n
Email: hello@procure4health.eu
\n
Telephone: +4670-2166768
\n
Internet address: www.vll.se
\n
Buyer profile: www.vll.se
\n
Roles of this organisation:
Buyer
\n
\n
\n
8.1 ORG-0019
Official name: Velindre National Health Service Trust
\n
Registration number: 993725619
\n
Postal address: Parc Nantgarw-Charnwood Court 2  
\n
Town: Cardiff
\n
Postcode: CF15 7QZ
\n
Country subdivision (NUTS): Cardiff and Vale of Glamorgan (UKL22)
\n
Country: United Kingdom
\n
Email: hello@procure4health.eu
\n
Telephone: 02921836445
\n
Internet address: www.velindre-tr.wales.nhs.uk
\n
Buyer profile: www.velindre-tr.wales.nhs.uk
\n
Roles of this organisation:
Buyer
\n
\n
\n
\n
11 Notice information
11.1 Notice information
Notice identifier/version: 09a11752-c437-4319-ba7e-1fbf82fbc467 - 01
\n
Form type: Planning
\n
Notice type: Prior information notice or a periodic indicative notice used only for information
\n
Notice dispatch date: 08-07-2024 09:06 +00:00
\n
Languages in which this notice is officially available: Spanish English
\n
\n
11.2 Publication information
Notice publication number: 00407805-2024
\n
OJ S issue number: 132/2024
\n
Publication date: 09-07-2024
\n
Estimated date of publication of a contract notice within this procedure: 01-11-2024
\n
\n
\n \n","opsummeringDA":{"card":{"titel":"RESEARCH AND DEVELOPMENT SERVICES AND RELATED CONSULTANCY SERVICESOPEN MARKET CONSULTATION OF PROCURE4HEALTH FOR THE FUTURE PRE-COMMERCIAL PROCUREMENT OF R&D SERVICES CONCERNING THE PRESERVATION OF FRESH BIOLOGICAL SAMPLES.","ordregiver":"Servicio Andaluz de Salud","ordregiverId":"998853621","publiceringsdato":"2024-07-09Z","cpvKode":"73000000","cpvTitel":"Forsknings- og udviklingsvirksomhed og hermed beslægtet konsulentvirksomhed","formulartype":"Planlægning","formulartypeKode":"planning","tidsfrister":[],"alleOrdregivere":["Servicio Andaluz de Salud","ZESPOL OPIEKI ZDROWOTNEJ W SUCHEJ BESKIDZKIEJd","Reseau Des Acheteurs Hospitaliers IDF","Skane Lans Landsting","Sykehusinnkjop HF","Turkiye Cumhuriyeti Saglik Bakanligi","Servizo Galego de Saúde","Region Hovedstaden","NHS National Services Scotland","SPMS - Servicos Partilhados do Ministerio da Saude EPE","Wojewodzki Szpital Specjalistyczny W Olsztynie","Azienda Regionale Per L'innovazionee Gli Acquisti SPA","Servicio Aragonés de la Salud","Mercurhosp asbl","Sihtasutus Pohja-Eesti Regionaalhaigla","5 Ygionomiki Periferia Thessalias & Stereas Elladas","Region Vasterbotten","Velindre National Health Service Trust"],"forventetOpstart":"01-11-2024","beskrivelse":"This Prior Information Notice announces the Open Market Consultation conducted by the PROCURE4HEALTH project and provides information about a potential future Pre-Commercial Procurement (PCP) of R&D services concerning the preservation of fresh biological samples. PROCURE4HEALTH aims to challenge the market to develop innovative solutions for advancing the preservation of biological samples for molecular biology studies. This initiative addresses the need for cost-efficient methods to preserve biological samples - ensuring the integrity and high yield of DNA, RNA, proteins, and metabolites - without requiring freezing and its associated infrastructure. These advancements are crucial for enhancing translational research, optimizing disease management, and improving patient outcomes in the context of precision medicine. PCP is an approach that allows public procurers to buy R&D from several competing suppliers in parallel, to compare alternative solution approaches, and to identify the best value-for-money solutions that the market can deliver to address their needs. It is split into three phases: solution design, prototype implementation, and validation and demonstration of the solutions. In PCP, there is a risk-benefit sharing under market conditions between the public procurer and the suppliers, and a clear separation between the PCP and the deployment of commercial volumes of end-products. The PCP procurement is exempted from the WTO Government Procurement Agreement (GPA), the EU public procurement directives and the national laws that implement them. The future PCP will be composed of three phases: Phase 1. Solution design: Phase 1 of the PCP will deal with the design of the solutions and verification of their technical and economic feasibility based on functional requirements. It will be implemented according to the tender documents in compliance with the procurement principles and the PCP methodology. Several technology providers will be selected for this phase. Phase 2. Prototype implementation: Phase 2 of the PCP concerns the development of the first prototypes of the solutions and testing at the procurers’ premises under controlled conditions. Several technology providers will be selected for this phase. Phase 3. Validation and demonstration of the solutions: Phase 3 of the PCP will deal with testing and validation of the selected solutions in operational environments. It will take place in several Member States. A minimum of 2 operators per challenge will be selected for this phase. The selected operators will retain ownership of the Intellectual Property Rights (IPRs) that they will generate during the PCP and will be able to use them to exploit the full market potential of the developed solutions. This PIN invites all interested technology providers from EU Member States and Associated Countries committed to perform R&D in the EU and/or Associated Countries, regardless of their size or governance structure, to take part in the Open Market Consultation. The Open Market Consultation aims to: (1) Validate the findings of the state-of-the-art analysis and the viability of the set of technical and financial provisions. (2) Raise awareness to the industry regarding the upcoming pre-commercial procurement (PCP). (3) Collect insights from the industry which can be used to fine tune the tender specifications. The market consultation may include one or more events, and a questionnaire to request information from the market. This Prior Information Notice is not a commitment to procure. The contracting authorities involved are not legally bound in any way by the outcome of the market consultation. No advantage or disadvantage will be given to any supplier /group of suppliers to the detriment of others during the market consultation and the sub-sequent competitive procedure for the award of contracts. The official communication language is English. The Open Market Consultation document will be published on the PROCURE4HEALTH website (www.procure4health.eu). The project has received funding from the Horizon Europe Framework Programme (HORIZON) under grant agreement n. 101057209. However, the European Union will not participate as a contracting authority in the procurement","bkSubTypeKode":"4","bkSubType":"Forhåndsmeddelelse kun anvendt til informationsformål – det generelle direktiv","erAendring":false},"indholdsType":"HENTET_FRA_TED","sekundaereOrdregivere":["ZESPOL OPIEKI ZDROWOTNEJ W SUCHEJ BESKIDZKIEJd","Reseau Des Acheteurs Hospitaliers IDF","Skane Lans Landsting","Sykehusinnkjop HF","Turkiye Cumhuriyeti Saglik Bakanligi","Servizo Galego de Saúde","Region Hovedstaden","NHS National Services Scotland","SPMS - Servicos Partilhados do Ministerio da Saude EPE","Wojewodzki Szpital Specjalistyczny W Olsztynie","Azienda Regionale Per L'innovazionee Gli Acquisti SPA","Servicio Aragonés de la Salud","Mercurhosp asbl","Sihtasutus Pohja-Eesti Regionaalhaigla","5 Ygionomiki Periferia Thessalias & Stereas Elladas","Region Vasterbotten","Velindre National Health Service Trust"],"udforelsesstedNutsCode":[],"udforelsesstedSubLand":[],"udforelsesstedLand":[],"udforelsesstedBy":[],"tilbudsfrister":[],"intressentfrister":[],"deltagelsefrister":[],"antalParts":1,"antalLots":0,"udbudsDokumenter":[]},"opsummeringEN":{"card":{"titel":"RESEARCH AND DEVELOPMENT SERVICES AND RELATED CONSULTANCY SERVICESOPEN MARKET CONSULTATION OF PROCURE4HEALTH FOR THE FUTURE PRE-COMMERCIAL PROCUREMENT OF R&D SERVICES CONCERNING THE PRESERVATION OF FRESH BIOLOGICAL SAMPLES.","ordregiver":"Servicio Andaluz de Salud","ordregiverId":"998853621","publiceringsdato":"2024-07-09Z","cpvKode":"73000000","cpvTitel":"Research and development services and related consultancy services","formulartype":"Planning","formulartypeKode":"planning","tidsfrister":[],"alleOrdregivere":["Servicio Andaluz de Salud","ZESPOL OPIEKI ZDROWOTNEJ W SUCHEJ BESKIDZKIEJd","Reseau Des Acheteurs Hospitaliers IDF","Skane Lans Landsting","Sykehusinnkjop HF","Turkiye Cumhuriyeti Saglik Bakanligi","Servizo Galego de Saúde","Region Hovedstaden","NHS National Services Scotland","SPMS - Servicos Partilhados do Ministerio da Saude EPE","Wojewodzki Szpital Specjalistyczny W Olsztynie","Azienda Regionale Per L'innovazionee Gli Acquisti SPA","Servicio Aragonés de la Salud","Mercurhosp asbl","Sihtasutus Pohja-Eesti Regionaalhaigla","5 Ygionomiki Periferia Thessalias & Stereas Elladas","Region Vasterbotten","Velindre National Health Service Trust"],"forventetOpstart":"01-11-2024","beskrivelse":"This Prior Information Notice announces the Open Market Consultation conducted by the PROCURE4HEALTH project and provides information about a potential future Pre-Commercial Procurement (PCP) of R&D services concerning the preservation of fresh biological samples. PROCURE4HEALTH aims to challenge the market to develop innovative solutions for advancing the preservation of biological samples for molecular biology studies. This initiative addresses the need for cost-efficient methods to preserve biological samples - ensuring the integrity and high yield of DNA, RNA, proteins, and metabolites - without requiring freezing and its associated infrastructure. These advancements are crucial for enhancing translational research, optimizing disease management, and improving patient outcomes in the context of precision medicine. PCP is an approach that allows public procurers to buy R&D from several competing suppliers in parallel, to compare alternative solution approaches, and to identify the best value-for-money solutions that the market can deliver to address their needs. It is split into three phases: solution design, prototype implementation, and validation and demonstration of the solutions. In PCP, there is a risk-benefit sharing under market conditions between the public procurer and the suppliers, and a clear separation between the PCP and the deployment of commercial volumes of end-products. The PCP procurement is exempted from the WTO Government Procurement Agreement (GPA), the EU public procurement directives and the national laws that implement them. The future PCP will be composed of three phases: Phase 1. Solution design: Phase 1 of the PCP will deal with the design of the solutions and verification of their technical and economic feasibility based on functional requirements. It will be implemented according to the tender documents in compliance with the procurement principles and the PCP methodology. Several technology providers will be selected for this phase. Phase 2. Prototype implementation: Phase 2 of the PCP concerns the development of the first prototypes of the solutions and testing at the procurers’ premises under controlled conditions. Several technology providers will be selected for this phase. Phase 3. Validation and demonstration of the solutions: Phase 3 of the PCP will deal with testing and validation of the selected solutions in operational environments. It will take place in several Member States. A minimum of 2 operators per challenge will be selected for this phase. The selected operators will retain ownership of the Intellectual Property Rights (IPRs) that they will generate during the PCP and will be able to use them to exploit the full market potential of the developed solutions. This PIN invites all interested technology providers from EU Member States and Associated Countries committed to perform R&D in the EU and/or Associated Countries, regardless of their size or governance structure, to take part in the Open Market Consultation. The Open Market Consultation aims to: (1) Validate the findings of the state-of-the-art analysis and the viability of the set of technical and financial provisions. (2) Raise awareness to the industry regarding the upcoming pre-commercial procurement (PCP). (3) Collect insights from the industry which can be used to fine tune the tender specifications. The market consultation may include one or more events, and a questionnaire to request information from the market. This Prior Information Notice is not a commitment to procure. The contracting authorities involved are not legally bound in any way by the outcome of the market consultation. No advantage or disadvantage will be given to any supplier /group of suppliers to the detriment of others during the market consultation and the sub-sequent competitive procedure for the award of contracts. The official communication language is English. The Open Market Consultation document will be published on the PROCURE4HEALTH website (www.procure4health.eu). The project has received funding from the Horizon Europe Framework Programme (HORIZON) under grant agreement n. 101057209. However, the European Union will not participate as a contracting authority in the procurement","bkSubTypeKode":"4","bkSubType":"Prior information notice used only for information – general directive","erAendring":false},"indholdsType":"HENTET_FRA_TED","sekundaereOrdregivere":["ZESPOL OPIEKI ZDROWOTNEJ W SUCHEJ BESKIDZKIEJd","Reseau Des Acheteurs Hospitaliers IDF","Skane Lans Landsting","Sykehusinnkjop HF","Turkiye Cumhuriyeti Saglik Bakanligi","Servizo Galego de Saúde","Region Hovedstaden","NHS National Services Scotland","SPMS - Servicos Partilhados do Ministerio da Saude EPE","Wojewodzki Szpital Specjalistyczny W Olsztynie","Azienda Regionale Per L'innovazionee Gli Acquisti SPA","Servicio Aragonés de la Salud","Mercurhosp asbl","Sihtasutus Pohja-Eesti Regionaalhaigla","5 Ygionomiki Periferia Thessalias & Stereas Elladas","Region Vasterbotten","Velindre National Health Service Trust"],"udforelsesstedNutsCode":[],"udforelsesstedSubLand":[],"udforelsesstedLand":[],"udforelsesstedBy":[],"tilbudsfrister":[],"intressentfrister":[],"deltagelsefrister":[],"antalParts":1,"antalLots":0,"udbudsDokumenter":[]}}